Emerging data have suggested lack of sleep as being a possible contributor to the development of Alzheimer’s disease pathology, placing insomnia as a prospective target to positively impact underlying disease progression. Diagnosis and treatment of insomnia can be a challenge in general, with even more complexities occurring in the population of Alzheimer's disease. Treatment data is overall limited. However, multiple non-pharmacological and pharmacological interventions are available for consideration for management